HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
L Fournier Selected Research
L Fournier Research Topics
Disease
9
Neoplasms (Cancer)
06/2019 - 03/2006
4
Ovarian Neoplasms (Ovarian Cancer)
06/2019 - 01/2018
3
Lymphadenopathy
06/2019 - 01/2019
3
Rupture
06/2019 - 01/2019
2
Renal Insufficiency (Renal Failure)
01/2019 - 04/2011
2
Fallopian Tube Neoplasms
01/2019 - 01/2019
1
Ovarian Epithelial Carcinoma
10/2021
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2020
1
Renal Cell Carcinoma (Grawitz Tumor)
12/2020
1
Gout
06/2020
1
Hyperuricemia
06/2020
1
Arterial Occlusive Diseases (Arterial Occlusive Disease)
02/2020
1
Leiomyosarcoma
10/2019
1
Leiomyoma (Uterine Fibroids)
10/2019
1
Residual Neoplasm
01/2018
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2016
1
Leukemia
11/2016
1
Chronic Kidney Failure (Chronic Renal Failure)
04/2011
1
Nephrogenic Fibrosing Dermopathy
04/2011
1
Hypoxia (Hypoxemia)
03/2006
1
Diaphragmatic Hernia
12/2001
1
Cross Infection (Nosocomial Infection)
02/2001
1
Congenital Diaphragmatic Hernias
05/2000
Drug/Important Bio-Agent (IBA)
3
Bevacizumab (Avastin)
FDA Link
06/2019 - 01/2019
3
Paclitaxel (Taxol)
FDA Link
Generic
06/2019 - 01/2019
3
Carboplatin (JM8)
FDA Link
Generic
06/2019 - 01/2019
3
Contrast Media
IBA
01/2019 - 02/2011
1
Nivolumab
IBA
12/2020
1
Allopurinol (Remid)
FDA Link
Generic
06/2020
1
Simvastatin (Zocor)
FDA Link
Generic
02/2020
1
Nafronyl (Naftidrofuryl)
IBA
02/2020
1
Indicators and Reagents (Reagents)
IBA
11/2016
1
Gadolinium
IBA
04/2011
1
Fluorescein-5-isothiocyanate (FITC)
IBA
02/2011
1
Albumins
IBA
02/2011
1
Integrins
IBA
03/2006
1
Transcription Factors (Transcription Factor)
IBA
03/2006
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
03/2006
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2006
1
Vascular Endothelial Growth Factors
IBA
03/2006
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2006
1
Metalloproteases (Metalloproteinases)
IBA
03/2006
1
adhesion receptor
IBA
03/2006
1
Atrasentan
IBA
12/2001
1
Methicillin (Metin)
FDA Link
02/2001
1
Endothelin-Converting Enzymes
IBA
05/2000
1
CGS 26303
IBA
05/2000
1
nitrofen
IBA
05/2000
1
Neprilysin (Neutral Endopeptidase)
IBA
05/2000
Therapy/Procedure
3
Minimally Invasive Surgical Procedures
06/2019 - 01/2019
3
Lymph Node Excision (Lymph Node Dissection)
06/2019 - 01/2019
3
Laparotomy
06/2019 - 01/2019
3
Adjuvant Chemotherapy
06/2019 - 01/2019
3
Appendectomy
06/2019 - 01/2019
3
Drug Therapy (Chemotherapy)
06/2019 - 01/2019
2
Cytoreduction Surgical Procedures
10/2021 - 01/2018
1
Neoadjuvant Therapy
10/2021
1
Treatment Delay
10/2019
1
Contraindications
01/2019
1
Intravenous Injections
04/2011
1
Injections
04/2011